Cargando…
Treatment of relapsed extranodal natural killer/T-cell lymphoma with bortezomib plus fludarabine
Extranodal NK/T cell lymphoma (ENKL) is a rare entity, associated with an aggressive clinical behavior and poor prognosis. The optimal treatment strategies, particularly for relapsed patients, have not been clearly determined. A 40-year-old female ENKL patient with orbital involvement as the first p...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574062/ https://www.ncbi.nlm.nih.gov/pubmed/28855986 http://dx.doi.org/10.3892/mco.2017.1364 |